CA
ALDR

Cliff Asness’s Alder Biopharmaceuticals ALDR Stock Holding History

Cliff Asness’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25,097
Closed -$257K – 2273
2018
Q4 		$257K Buy
25,097
+4,304
+21% +$55.1K ﹤0.01% 2014
2018
Q3 		$346K Buy
+20,793
New +$376K ﹤0.01% 2069
2016
Q4 		– Sell
-23,319
Closed -$764K – 2311
2016
Q3 		$764K Sell
23,319
-4,177
-15% -$127K ﹤0.01% 1811
2016
Q2 		$687K Sell
27,496
-9,299
-25% -$252K ﹤0.01% 1746
2016
Q1 		$901K Buy
36,795
+6,579
+22% +$152K ﹤0.01% 1617
2015
Q4 		$998K Sell
30,216
-19,636
-39% -$664K ﹤0.01% 1572
2015
Q3 		$1.63M Buy
49,852
+23,718
+91% +$1.01M ﹤0.01% 1222
2015
Q2 		$1.38M Buy
+26,134
New +$950K ﹤0.01% 1348

Other funds holding ALDR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Cliff Asness's ALDR Position: Q1 2019 in Review

Cliff Asness sold out of Alder Biopharmaceuticals (ALDR) in Q1 2019, closing a stake of 25,097 shares — an estimated $257K sold.

Cliff Asness first reported a position in ALDR in Q2 2015 and held it in 8 quarters. The position peaked at $1.63M in Q3 2015. 123 funds tracked by Wall St. Rank hold ALDR as of Q1 2019.

  • Cliff Asness reported no remaining Alder Biopharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Cliff Asness sold 25,097 Alder Biopharmaceuticals shares in Q1 2019, an estimated $257K.
  • Cliff Asness first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 8 quarters.
  • Cliff Asness's Alder Biopharmaceuticals position peaked at $1.63M in Q3 2015.
  • 123 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2019.

Based on AQR Capital Management's 13F filing for Q1 2019, filed 14 May 2019.